A Blend Of Olive Polyphenols

THE TREPHENOL® DIFFERENCE
Natural, Non-GMO, Chemical Free Extraction from Olives Harvested in Spain.
A Unique Concentration. Clinically Evaluated.
TREPHENOL®. A POWERFUL AND NATURAL ANTI-INFLAMMATORY FORMULATION
TrePhenol® is a blend of olive polyphenols (principally hydroxytyrosol, tyrosol, and their derivatives) developed and clinically tested by Oliventures and our partners in Spain. TrePhenol® is 100% natural (not synthesized or otherwise chemically produced) and is extracted from olives, not olive leaves. It is GRAS, non-GMO, and is tested for chemical and pesticide contamination. TrePhenol® is manufactured using an all-natural process that is water-based using no chemicals or solvents.
WHICH PRODUCT IS RIGHT FOR YOU?
Our OliPura® and PureVida® brands of supplements are formulated to address general inflammation as the driver of health issues our core customers are focused on. Depending on your unique needs and areas of concern, you may choose to support your body’s fight against inflammation with a targeted supplement such as OliPura Joint, Heart or Daily Living or with an advanced nutrition product like PureVida which provides broad based support for heart, breast and joint health.*
JOINT
DAILY LIVING
RX
HEART
PUREVIDA
CARDIOLIVE 10X
CARDIOLIVE 10X – BUY 3 GET 1 FREE
CARDIOLIVE 25x
CARDIOLIVE 25X – BUY 3 GET 1 FREE
NOT ALL OLIVE PRODUCTS ARE CREATED EQUAL
Different olive oils have different flavor, shelf life, quality, and polyphenol content depending on where the olives were grown, how they were processed, and their varietal makeup. Polyphenol content is also affected by environmental factors including soil type, sun exposure, and rainfall.15
Just as olive oils vary in polyphenol content, so do olive based products, which include natural olive fruit extracts such as TrePhenol®, olive leaf supplements, and synthetic or chemically processed ingredients. For example, olive leaf supplements, which are made with olive leaf extracts, do not contain the same levels of free hydroxytyrosol and tyrosol as those found in olive fruit extracts and olive oil products. Olive leaf extracts typically contain oleuropein, which the body converts to hydroxytyrosol on a limited basis. Similarly, synthetics and chemically produced extracts may introduce chemicals not normally associated with natural products.

Polyphenols derived from olives, which are a part of the Mediterranean diet. TrePhenol® is natural – no chemicals are used in the extraction process. It is tested for heavy metals and pesticide contamination. TrePhenol® is produced in Spain and encapsulated into products in the U.S.
Dietary supplements containing olive leaf extracts that typically contain high levels of oleuropein, which the body converts to hydroxytyrosol on a limited basis. Olive leaf is not part of the Mediterranean diet.

May include, in addition to other chemicals, synthetic hydroxytyrosol, oleuropein that has been chemically converted to hydroxytyrosol and extracts that have been chemically produced.
Preclinical in vitro testing of TrePhenol® conducted by Oliventures in the U.S. has successfully validated some of the reported antioxidant and anti-inflammatory properties of hydroxytyrosol and tyrosol in the areas of cardiovascular and breast health.**
An initial clinical trial of PureVida in Spain (with 45 patients) has suggested health benefits for women taking aromatase inhibitors. Because only one trial, with 45 participants, has been performed (and the results of the trial have not yet been peer reviewed), more research is needed to confirm that the results of that trial are valid.*
Full details of the tests and results are available for your Health Care Provider to review here.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
** In a prospective, multicenter, pilot study of 45 postmenopausal women (mean age 59 years) with Stage 0-IIIA hormone receptor−positive breast cancer receiving stable doses of adjuvant aromatase inhibitor therapy for 2 to 5 years from their diagnosis, PureVida® significantly reduced CRP (C-reactive protein, a key marker of inflammation) levels (p<0.05). In 45 patients examined for safety, reported adverse events (AEs) included abdominal pain in 1 patient (2.2%), constipation in 5 patients (11.1%), headache in 3 patients (6.7%), and abnormal product taste (fish taste) in 14 patients (31.1%). No patients had to discontinue therapy due to AEs. This study was conducted by Oliventures. There has been substantial separate research into the potential benefits of each of the ingredients in PureVida. The PureVida trial has not been peer reviewed and more research is needed before drawing any final conclusions.